UnitedHealth (0R0O) Share Forecast & Price Target

Compare

4 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0R0O Analyst Ratings

Moderate Buy

18 Buy

2 Hold

2 Sell

Based on 22 analysts giving stock ratings to

UnitedHealth

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0R0O Stock 12 Month Forecast

Average Price Target

$360.14

▲(1.20% Upside)

Based on 22 Wall Street analysts offering 12 month price targets for UnitedHealth in the last 3 months. The average price target is $360.14 with a high forecast of $440.00 and a low forecast of $198.00. The average price target represents a 1.20% change from the last price of $355.86.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"197":"$197","380":"$380","563":"$563","288.5":"$288.5","471.5":"$471.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":440,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$440.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":360.14,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$360.14</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":198,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$198.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[197,288.5,380,471.5,563],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,345.185,352.47846153846154,359.7719230769231,367.06538461538463,374.3588461538462,381.6523076923077,388.9457692307692,396.23923076923074,403.5326923076923,410.82615384615383,418.1196153846154,425.4130769230769,432.70653846153846,{"y":440,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,345.185,346.3353846153846,347.4857692307692,348.63615384615383,349.78653846153844,350.93692307692305,352.08730769230766,353.2376923076923,354.38807692307694,355.53846153846155,356.68884615384616,357.83923076923077,358.9896153846154,{"y":360.14,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,345.185,333.8630769230769,322.54115384615386,311.21923076923076,299.89730769230766,288.5753846153846,277.2534615384615,265.9315384615385,254.60961538461538,243.2876923076923,231.96576923076924,220.64384615384614,209.32192307692307,{"y":198,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":558.33,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":558.33,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":558.33,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 56,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":560.394,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 60,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":560.394,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 66,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":560.394,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":562.466,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 54,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":562.466,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 64,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":297.905,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 72,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":321.477,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 65,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":235.039,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 52,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":303.518,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 53,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":345.185,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 40,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$440.00

Average Price Target$360.14

Lowest Price Target$198.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

David Windley

Jefferies

$409

Buy

14.93%

Upside

Reiterated

10/16/25

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH) and Veeva Systems (NYSE: VEEV)

Lance Wilkes

Bernstein

$433

Buy

21.68%

Upside

Reiterated

10/16/25

Bernstein Reaffirms Their Buy Rating on UnitedHealth (UNH)

Ryan Langston

TD Cowen

$275→$335

Hold

-5.86%

Downside

Reiterated

10/16/25

Cautious Hold on UnitedHealth Amid Medicare Advantage Uncertainties and Raised Price Target

Ben Hendrix

RBC Capital

$286

Buy

-19.63%

Downside

Reiterated

10/15/25

UnitedHealth (UNH) Gets a Buy from RBC Capital

David S Macdonald

Truist Financial

$365→$410

Buy

15.21%

Upside

Reiterated

10/14/25

UnitedHealth price target raised to $410 from $365 at TruistUnitedHealth price target raised to $410 from $365 at Truist

Scott Fidel

Goldman Sachs

$406

Buy

14.09%

Upside

Reiterated

10/14/25

Goldman Sachs Sticks to Their Buy Rating for UnitedHealth (UNH)

Sarah James

Cantor Fitzgerald

$440

Buy

23.64%

Upside

Reiterated

10/10/25

UnitedHealth (UNH) Gets a Buy from Cantor Fitzgerald

Lisa Gill

J.P. Morgan

$310→$425

Buy

19.43%

Upside

Reiterated

10/09/25

UnitedHealth (UNH) Gets a Buy from J.P. Morgan

Andrew Mok CFA

Barclays

$352→$386

Buy

8.47%

Upside

Reiterated

10/09/25

UnitedHealth (UNH) Gets a Buy from Barclays

Ann Hynes

Mizuho Securities

$300→$430

Buy

20.83%

Upside

Reiterated

10/08/25

UnitedHealth price target raised to $430 from $300 at MizuhoUnitedHealth price target raised to $430 from $300 at Mizuho

Kevin Fischbeck

Bank of America Securities

$390

Hold

9.59%

Upside

Reiterated

10/08/25

UnitedHealth's Earnings Outlook: Balancing Potential Upside with Uncertainty

Matthew Gillmor CFA

KeyBanc

$350→$400

Buy

12.40%

Upside

Reiterated

10/08/25

UnitedHealth price target raised to $400 from $350 at KeyBancUnitedHealth price target raised to $400 from $350 at KeyBanc

Sidharth Sahoo

HSBC

$260

Sell

-26.94%

Downside

Reiterated

10/08/25

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ) and UnitedHealth (NYSE: UNH)

A.J. Rice

UBS

$378

Buy

6.22%

Upside

Assigned

10/06/25

UnitedHealth (UNH) Receives a Buy from UBS

Stephen Baxter

Wells Fargo

$267→$400

Buy

12.40%

Upside

Reiterated

10/06/25

UnitedHealth price target raised to $400 from $267 at Wells FargoUnitedHealth price target raised to $400 from $267 at Wells Fargo

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

David Windley

Jefferies

$409

Buy

14.93%

Upside

Reiterated

10/16/25

Analysts Offer Insights on Healthcare Companies: UnitedHealth (NYSE: UNH) and Veeva Systems (NYSE: VEEV)

Lance Wilkes

Bernstein

$433

Buy

21.68%

Upside

Reiterated

10/16/25

Bernstein Reaffirms Their Buy Rating on UnitedHealth (UNH)

Ryan Langston

TD Cowen

$275→$335

Hold

-5.86%

Downside

Reiterated

10/16/25

Cautious Hold on UnitedHealth Amid Medicare Advantage Uncertainties and Raised Price Target

Ben Hendrix

RBC Capital

$286

Buy

-19.63%

Downside

Reiterated

10/15/25

UnitedHealth (UNH) Gets a Buy from RBC Capital

David S Macdonald

Truist Financial

$365→$410

Buy

15.21%

Upside

Reiterated

10/14/25

UnitedHealth price target raised to $410 from $365 at TruistUnitedHealth price target raised to $410 from $365 at Truist

Scott Fidel

Goldman Sachs

$406

Buy

14.09%

Upside

Reiterated

10/14/25

Goldman Sachs Sticks to Their Buy Rating for UnitedHealth (UNH)

Sarah James

Cantor Fitzgerald

$440

Buy

23.64%

Upside

Reiterated

10/10/25

UnitedHealth (UNH) Gets a Buy from Cantor Fitzgerald

Lisa Gill

J.P. Morgan

$310→$425

Buy

19.43%

Upside

Reiterated

10/09/25

UnitedHealth (UNH) Gets a Buy from J.P. Morgan

Andrew Mok CFA

Barclays

$352→$386

Buy

8.47%

Upside

Reiterated

10/09/25

UnitedHealth (UNH) Gets a Buy from Barclays

Ann Hynes

Mizuho Securities

$300→$430

Buy

20.83%

Upside

Reiterated

10/08/25

UnitedHealth price target raised to $430 from $300 at MizuhoUnitedHealth price target raised to $430 from $300 at Mizuho

Kevin Fischbeck

Bank of America Securities

$390

Hold

9.59%

Upside

Reiterated

10/08/25

UnitedHealth's Earnings Outlook: Balancing Potential Upside with Uncertainty

Matthew Gillmor CFA

KeyBanc

$350→$400

Buy

12.40%

Upside

Reiterated

10/08/25

UnitedHealth price target raised to $400 from $350 at KeyBancUnitedHealth price target raised to $400 from $350 at KeyBanc

Sidharth Sahoo

HSBC

$260

Sell

-26.94%

Downside

Reiterated

10/08/25

Analysts Offer Insights on Healthcare Companies: Johnson & Johnson (NYSE: JNJ) and UnitedHealth (NYSE: UNH)

A.J. Rice

UBS

$378

Buy

6.22%

Upside

Assigned

10/06/25

UnitedHealth (UNH) Receives a Buy from UBS

Stephen Baxter

Wells Fargo

$267→$400

Buy

12.40%

Upside

Reiterated

10/06/25

UnitedHealth price target raised to $400 from $267 at Wells FargoUnitedHealth price target raised to $400 from $267 at Wells Fargo

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering UnitedHealth

1 Month

xxx

Success Rate

26/35 ratings generated profit

Average Return

+2.46%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 74.29% of your transactions generating a profit, with an average return of +2.46% per trade.

3 Months

xxx

Success Rate

25/35 ratings generated profit

Average Return

+3.95%

reiterated a xxx

rating 12 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 71.43% of your transactions generating a profit, with an average return of +3.95% per trade.

1 Year

Scott FidelGoldman Sachs

Success Rate

36/44 ratings generated profit

Average Return

+21.31%

reiterated a buy rating 8 days ago

Copying Scott Fidel's trades and holding each position for 1 Year would result in 81.82% of your transactions generating a profit, with an average return of +21.31% per trade.

2 Years

xxx

Success Rate

39/44 ratings generated profit

Average Return

+44.42%

assigned a xxx

rating 16 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 88.64% of your transactions generating a profit, with an average return of +44.42% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0R0O Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0R0O has received 40 Buy Ratings, 6 Hold Ratings, and 2 Sell Ratings. 0R0O average Analyst price target in the past 3 months is 360.14.

Each month's total comprises the sum of three months' worth of ratings.

0R0O Financial Forecast

0R0O Earnings Forecast

Next quarter’s earnings estimate for 0R0O is $2.82 with a range of $2.22 to $3.57. The previous quarter’s EPS was $4.08. 0R0O beat its EPS estimate 0.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year 0R0O has Preformed in-line its overall industry.

0R0O Sales Forecast

Next quarter’s sales forecast for 0R0O is $113.04B with a range of $109.94B to $114.63B. The previous quarter’s sales results were $111.62B. 0R0O beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year 0R0O has Preformed in-line its overall industry.

0R0O Stock Forecast FAQ

What is GB:0R0O’s average 12-month price target, according to analysts?

Based on analyst ratings, Unitedhealth Group Inc.’s 12-month average price target is 360.14.

What is GB:0R0O’s upside potential, based on the analysts’ average price target?

Unitedhealth Group Inc. has 1.20% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Unitedhealth Group Inc. a Buy, Sell or Hold?

Unitedhealth Group Inc. has a consensus rating of Moderate Buy, which is based on 18 buy ratings, 2 hold ratings and 2 sell ratings.

What is Unitedhealth Group Inc.’s share price target?

The average share price target for Unitedhealth Group Inc. is 360.14. This is based on 22 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is $440.00 ,and the lowest forecast is $198.00. The average share price target represents 1.20% Increase from the current price of $355.86.

What do analysts say about Unitedhealth Group Inc.?

Unitedhealth Group Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 22 Wall Streets Analysts.

How can I buy shares of Unitedhealth Group Inc.?

To buy shares of GB:0R0O, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

UnitedHealth (0R0O) Share Forecast & Price Target

0R0O Analyst Ratings

0R0O Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering UnitedHealth

0R0O Analyst Recommendation Trends

0R0O Financial Forecast

0R0O Earnings Forecast

0R0O Sales Forecast

0R0O Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts